Anavex Life Sciences Corp. (AVXL) analyst actions
Rating and price-target actions on AVXL in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AVXL overview →
5 measured AVXL analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Anavex Life Sciences Corp. (AVXL) And Encourages Shareholders to Reach Out | Press release | +0.00% | -3.03% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Anavex Life Sciences Corp. (AVXL) And Encourages Stockholders to Reach Out | Press release | -0.18% | -0.88% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Anavex Life Sciences Corp. (AVXL) And Encourages Stockholders to Reach Out | Press release | -0.73% | -7.98% | |
| Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia | Press release | -0.59% | -5.67% | |
| Anavex Initiates Regulatory Submission of Oral Blarcamesine for Alzheimer’s Disease to European Medicines Agency (EMA) | Press release | -5.00% | -0.28% |
Keep exploring
More AVXL: earnings → · SEC filings → · AVXL overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NEWLINK GENETICS (NLNK) | 843 | 0.00% | 49% |
| Integra LifeSciences Holdings Corporation (IART) | 841 | -0.13% | 43% |
| Assertio Holdings, Inc. (ASRT) | 833 | -0.02% | 46% |
| Masimo Corporation (MASI) | 833 | -0.02% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.